This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on May 22, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Q--NGS services to support clinical research

Awarded

75N98026Q00369Federal

Submission Closed05/29/2026, 01:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 621511

New

International

In-Vitro Diagnostics, Point of Care Testing & Pathology Services Project_1717

Solicitation # Project_1717

Supply Chain Coordination Limited, acting for NHS Supply Chain, is establishing an open national framework agreement for the provision of In-Vitro Diagnostic Devices, Point of Care Testing Products, and Related Pathology Services. The scope of the procurement is extensive, covering pathology managed services, reagent rental agreements, pathology software, and core laboratory equipment and consumables across multiple disciplines, including biochemistry, microbiology, immunology, cellular pathology, virology, haematology, genomics, molecular testing, and reproductive sciences. Additionally, the framework includes point of care testing and specimen collection and storage. The procurement is organized into three distinct lots: Pathology Managed Services, Pathology Software Solutions, and Diagnostics Testing Solutions. The estimated total value for the initial period is 703,101,796 GBP excluding VAT, with a potential total value of approximately 2,545,824,000 GBP excluding VAT over the full eight-year framework duration. The estimated contract period runs from October 18, 2027, to October 17, 2029, with an overall framework end date of October 17, 2035. Proposals must be submitted electronically by December 16, 2026. Evaluation for Lots 1 and 2 is weighted at 80 percent for non-financial quality, 10 percent for social value, and 10 percent for price. Lot 3 is evaluated based on 60 percent non-financial quality, 30 percent cost, and 10 percent social value.

Supply Chain Coordination Limited

POSTED

DEADLINE

Pathology ServicesThis subcontract for Pathology Services involves providing diagnostic pathology support for prime contractors working on projects for the Kingston University Higher Education Corporation. The scope of work includes the collection of biological samples and the execution of laboratory analysis utilizing specialized diagnostic equipment and pathology software to deliver comprehensive test results and diagnostic reports. To ensure quality and compliance, the provider must hold recognized laboratory accreditation, such as ISO 15189 or equivalent UK standards. Interested parties must submit their responses by the deadline of November 27, 2026, as specified in the solicitation posted on October 28, 2026.

Kingston University Higher Education Corporation

POSTED

DEADLINE

Clinical Blood Donor Panel Testing (Reference Laboratory Services)This subcontract involves providing clinical blood donor panel testing as a reference laboratory service for prime contractors supporting the Department of Veterans Affairs in North Chicago. The scope of work includes screening for various pathogens, including HIV, HBV, HCV, West Nile Virus, Chagas, Babesia, HTLV-I/II, and Anti-CMV, utilizing FDA-approved platforms. The service provider is responsible for managing specimen storage and conducting confirmation testing on all reactive results, with a strict requirement to deliver test result files within 24 hours. To ensure clinical quality and safety, the contractor must maintain CLIA certification and adhere to rigorous standards set by AABB, CAP, TJC, OSHA, the CDC, and the DoD. This opportunity falls under NAICS code 621511 and is managed through the Department of Veterans Affairs Network Contract Office 12.

252-NETWORK Contract Office 12 (36C252)

POSTED

DEADLINE

Q301--Blood Donor Panel Testing for Captain James A. Lovell Federal Health Care Center (FHCC)

Solicitation # 36C25227Q0071

The Department of Veterans Affairs is conducting market research via a sources sought synopsis to identify qualified providers for blood donor panel testing services at the Captain James A. Lovell Federal Health Care Center in North Chicago, Illinois. This requirement, categorized under NAICS code 621511 for Medical Laboratories, involves a five year ordering period consisting of five one year priced periods starting March 1, 2027. The selected contractor must provide all labor, materials, and expertise to perform a variety of tests, including standard donor panels, Anti-CMV, Chagas Antibody, West Nile Virus, and Babesia DNA/RNA, with estimated annual quantities ranging from 15 to 6,200 tests per category. The contractor must adhere to strict regulatory standards from the FDA, AABB, CAP, TJC, OSHA, CDC, and Department of Defense. Key performance requirements include a 95 percent success rate for reporting results within 24 hours of specimen receipt, with confirmation testing completed within seven calendar days. The contractor is responsible for providing specimen shipment containers and maintaining all necessary certifications, including CLIA and FDA approvals. The government reserves the right to conduct physical inspections of the contractor's facilities. Interested parties must submit organizational details and tailored capability statements by November 3, 2026, to help the government determine if the contract will be a small business set-aside, sole sourced, or open for full competition.

252-NETWORK Contract Office 12 (36C252)

POSTED

DEADLINE

Initial Drug and Alcohol Screening ServicesThis subcontract opportunity with the City of Camden involves providing initial drug and alcohol screening services for prime contractors working on occupational health projects. The selected provider will be responsible for collecting specimens and performing laboratory analysis for alcohol and controlled substances using certified equipment and collection kits. To qualify, the service provider must operate a licensed medical facility or a CLIA certified laboratory and must be capable of delivering detailed screening reports and test results. The solicitation is categorized under NAICS code 621511 and was posted on October 26, 2026. Interested parties must submit their responses by the deadline of November 20, 2026, at 4:00 PM. This contract ensures that personnel on city projects meet necessary health and safety standards through professional medical screening and reporting.

POSTED

DEADLINE

Certified Drug Testing and Laboratory ServicesThis subcontract for Certified Drug Testing and Laboratory Services involves providing comprehensive drug screening and laboratory analysis for prime contractors working on Alabama Department of Workforce projects. The selected provider must offer local specimen collection sites and conduct all testing according to approved laboratory standards, ensuring the delivery of certified results and reports for employees. To ensure accuracy and compliance, the contractor is required to maintain CAP or NIDA accreditation and implement rigorous quality control and chain-of-custody procedures. This opportunity falls under NAICS code 621511 and is associated with the Alabama Human Resources agency.

POSTED

DEADLINE

Solicitation # SRC0000037369

The Alabama Department of Workforce is seeking a qualified vendor to establish an agreement for drug testing services. To be eligible, the selected laboratory must be approved by the College of American Pathologists or the National Institute on Drug Abuse and maintain strict written procedures for chain of custody and quality control. This includes the use of internal quality controls, blind samples for accuracy, a formal internal review and certification process for results, and robust security measures to prevent the adulteration of specimens. Additionally, the vendor must provide local sites for employee testing. The contract is managed by the State of Alabama Office of the Chief Procurement Officer and is subject to a total cost limit of 25,000 dollars or a maximum duration of five years, with the possibility of annual renewals. Award evaluation will be based on pricing, cost realism, and the verification of professional licenses and insurance. Vendors must be registered with the Alabama Secretary of State if they are foreign entities and must comply with the Beason-Hammon Alabama Taxpayer and Citizen Protection Act via E-Verify documentation. All submissions and inquiries must be processed electronically through the Alabama Buys Supplier Portal.

POSTED

DEADLINE

Forensic DNA Testing and STR/Y STR AnalysisThis subcontract for the City of Charlotte involves providing specialized forensic DNA testing and STR/Y STR analysis for prime contractors supporting Charlotte-Mecklenburg Police Department projects. The scope of work includes the screening of evidence, DNA extraction via manual or robotic methods, and the use of Globalfiler and Applied Biosystems 3500/3500xl Genetic Analyzers to amplify and type samples. Final analysis is conducted using GeneMapper ID-X software to deliver forensic reports and CODIS-eligible DNA profiles. To qualify, the provider must maintain ISO/IEC 17025 accreditation and ensure full compliance with 2025 FBI Quality Assurance Standards. The opportunity was posted on October 23, 2026, with a response deadline of November 23, 2026. This project falls under NAICS code 621511 and is managed through the City of Charlotte's procurement system.

POSTED

DEADLINE

Postmortem Respiratory Virus AnalysisThis subcontract for Postmortem Respiratory Virus Analysis involves performing laboratory studies to identify respiratory viruses in postmortem samples for prime contractors working on Middlesex County Office of the Medical Examiner projects. The selected provider will be responsible for executing respiratory virus panels to identify viral pathogens utilizing PCR or NGS equipment and delivering the resulting viral panel reports. To ensure quality and regulatory compliance, the contractor must maintain CLIA certification and adhere to all molecular pathology standards. This opportunity is categorized under NAICS code 621511 and is managed through the New Jersey Office of Purchasing, with a response deadline set for November 13, 2026.

POSTED

DEADLINE

Synthetic Cannabinoid Screening and ConfirmationThis subcontract involves providing specialized screening and confirmation services for synthetic cannabinoid analytes to support prime contractors on projects for the Middlesex County Office of the Medical Examiner. Utilizing LC-MS/MS instrumentation, the contractor is responsible for identifying specific substances, including 4-fluoro-MDMB-BINACA and 5-fluoro-MDMB-PICA, while strictly adhering to established forensic toxicology standards. The primary deliverable for this engagement is the provision of detailed analytical reports confirming the presence of these synthetic cannabinoids. Managed by the New Jersey Office of Purchasing under NAICS code 621511, the opportunity was posted on October 23, 2026, with a response deadline of November 13, 2026. This technical engagement ensures that forensic analysis meets the rigorous requirements necessary for medical examiner investigations within Middlesex County.

POSTED

DEADLINE

Designer Drug and Novel Psychoactive Substance (NPS) TestingThis subcontract involves providing specialized forensic testing for emerging designer drugs and novel psychoactive substances on behalf of prime contractors for the Middlesex County Office of the Medical Examiner. The scope of work focuses on the analysis of synthetic opioids, benzodiazepines, and fentanyl-related substances using advanced LC-MS/MS or HRMS technology to identify novel molecular structures and deliver detailed confirmation reports. Managed through the New Jersey Office of Purchasing under NAICS code 621511, the contract requires the service provider to hold specialized forensic toxicology certification for NPS. The solicitation was posted on October 23, 2026, with a response deadline set for November 13, 2026.

POSTED

DEADLINE

Postmortem Toxicology I & II Testing ServicesThis subcontract for Postmortem Toxicology I and II Testing Services involves providing comprehensive screening and confirmation for controlled substances, abuse, and therapeutic substances to support prime contractors working with the Middlesex County Office of the Medical Examiner. The selected provider will be responsible for conducting analysis of standard toxicology panels utilizing advanced methodologies such as HPLC, GC-MS, or LC-MS/MS to deliver detailed analytical reports on substance presence and concentration. To ensure the integrity of the results, the contractor must maintain medical laboratory certification and strictly adhere to established forensic toxicology standards. This opportunity is managed through the New Jersey Office of Purchasing under NAICS code 621511, with a response deadline set for November 13, 2026.

Office of Purchasing

POSTED

5 days ago

DEADLINE

in 16 days

AI Contract Overview

The National Institutes of Health, Office of the Director, Office of Acquisitions, is seeking to award a firm-fixed-price purchase order for Next Generation Sequencing (NGS) services to support clinical and research activities related to bone marrow failure syndromes, including aplastic anemia and related disorders, under a competitive combined synopsis/solicitation issued in accordance with FAR Subpart 12.6. The solicitation, numbered 75N98026Q00369, is reserved exclusively for small business concerns certified under NAICS code 621511 (Medical Laboratories), with a small business size standard of $41.5 million. The contract requires the contractor to perform NGS services at their own facility, processing 144 samples with a Hematology Profile Panel, delivering detailed reports for each sample within a typical turnaround time of 7 to 10 days. All reports containing patient-sensitive information must be securely accessible via password-protected web portals, and the contractor is responsible for supplying all specimen shipment materials, including shipping labels and transport systems, as well as providing logistical support for sample receipt and coordination. Performance will be evaluated based on technical capability—including gene panel coverage, sequencing accuracy, turnaround time, and data reporting—followed by past performance in similar genomic services, with price considered but secondary to the combined importance of technical excellence and proven track record. The period of performance runs from June 1, 2026, through May 31, 2027. Offerors must be currently registered in the System for Award Management (SAM), provide their Unique Entity Identifier (UEI) and Taxpayer Identification Number (TIN), submit business size certification, and include a completed FAR 52.212-3 representation and certification form. Proposals must be submitted electronically to [email hidden] by 9:00 a.m. EDT on May 29, 2026, and must include unit and total pricing, shipping and handling costs, delivery terms, and sufficient detail to demonstrate capability. Invoicing must be submitted monthly through the Department of Treasury’s Invoice Processing Platform (IPP) and duplicated via email to [email hidden], with all invoices tied to specific Contract Line Item Numbers and limited to services rendered within the billing cycle. The Government will evaluate submissions for best value, prioritizing technical merit above cost, and will accept samples shipped from NIH’s National Heart, Lung

General Info

NIH seeks small business proposals for firm-fixed-price NGS clinical research services, deadline May 29, 2026.

Agency

Department Of Health And Human Services → National Institutes Of Health Olao

Contract Value

$216,000

NAICS

621511 - Medical Laboratories

Place of Performance

MD, USA

Set-Aside

SBA

Awardee

GENOMIC TESTING COOPERATIVE, LCA

Award Issued Date

06/05/2026, 12:00:00 AM UTC

Documents

Amendment 0002 to RFQ 75N98026Q00369 for NGS Services

amendment

High

RFQ 75N98026Q00369/0001 Next Generation Sequencing Services

rfq

High

RFQ 75N98026Q00369 Amendment 0003 for NGS Services

amendment

High

RFQ 75N98026Q00369 Next Generation Sequencing Services

rfq

High

Solicitation 75N98026Q00369 - Next Generation Sequencing Services for Bone Marrow Failure Patients

rfp

High

AI Contract Breakdown

Uniform Contract Format

Timeline

2 updates

PhaseAwarded

PostedMay 15

Combined Synopsis

Notice updatedMay 21

Notice details unchanged. Attachments may have changed.

Notice updatedMay 22

Notice details unchanged. Attachments may have changed.

AwardedJun 5

Contract was awarded

Submission Closed

05/29/2026, 01:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao

Contacts1 person available

OfficeBETHESDA, MD, 20892, USA

Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao

Office AddressBETHESDA, MD, 20892, USA

Contacts

CAPOBIANCO NICHOLAS S

contact@example.gov

+1 (555) 000-0000

Full Description

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.
(ii) The solicitation number is 75N98026Q00369. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold.
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a firm-fixed-price purchase order to the responsible offeror whose proposal represents the best value to the Government.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective March 13, 2026.
(iv) (iv) The associated NAICS code is 621511 ¿ Medical Laboratories, and the small business size standard is $41.5 million.
This requirement is set aside for small business concerns.